Filana Therapeutics, Inc. Common Stock FLNA
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-13T02:12:00.225Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T00:56:09.223354531Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-13T02:11:59.008071+00:00
Filana Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | 1.05 | 187.9% | 16.7% | |||
| 55Δ | 1.87 | 276.8% | 16.7% | |||
| 60Δ | 2.70 | 365.6% | 16.7% | |||
| 65Δ | 4.02 | 404.1% | 12.9% | |||
| 70Δ | 5.64 | 413.2% | 6.9% | |||
| 75Δ | ||||||
| 80Δ | 0.59 | 586.2% | 101.8% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.05
- IV
- 187.9%
- B/E move
- 16.7%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.87
- IV
- 276.8%
- B/E move
- 16.7%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.70
- IV
- 365.6%
- B/E move
- 16.7%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.02
- IV
- 404.1%
- B/E move
- 12.9%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 5.64
- IV
- 413.2%
- B/E move
- 6.9%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 0.59
- IV
- 586.2%
- B/E move
- 101.8%
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
FTRE
Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. The company is headquartered in Durham, North Carolina.
More →FULC
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined diseases in areas…
More →GALT
Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic, cancerous and other diseases. The…
More →GANX
Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. The company is…
More →GENB
Generate Biomedicines, Inc. is an innovative biotechnology company at the forefront of protein therapeutics development, leveraging advanced genetic engineering and artificial…
More →GERN
Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The…
More →